Morgan Stanley upgraded Salesforce to Overweight from Equal Weight with a price target of $350, up from $290. The firm sees “several vectors” for Salesforce to drive top-line upside versus “muted” investor growth expectations, the analyst tells investors. While generative AI, or GenAI, app demand is likely to ramp in the second half of 2024, Salesforce’s Data Cloud offering will likely see traction earlier as organizations look to prep their data for GenAI and the company’s “unrivaled breadth” of Front Office workflows and depth of customer data well positions Salesforce to benefit from GenAI innovations, the analyst added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CRM:
- Salesforce downgraded to Equal Weight from Overweight at Wells Fargo
- Salesforce’s Slack turnover continues with COO leaving, Fortune says
- Snap upgraded, Roku downgraded: Wall Street’s top analyst calls
- Salesforce upgraded to Outperform from Peer Perform at Wolfe Research
- Salesforce Stock (NYSE:CRM): Growth Will Accelerate. Should You Buy?